This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example,...

The book deals with collusion between firms on both sides of a market that is immune to deviations by coalitions. We study this issue using an infinitely countably repeated game with discounting of future single period payoffs. A strict strong perfect equilibrium is the main solution concept...

Spieltheoretische Betrachtung von Oligopolen und Kollusion in Kontraktmärkten -- Experimentelle Untersuchung zum Einfluss von Monitoring, Kommunikation, Absprachetypen und Markthistorie auf Kollusion -- Statistische Hypothesenüberprüfung anhand einer Inhaltsanalyse und multivariaten...

Foreword to the Two-Volume Series -- Introduction to This Study -- Introduction to Part I: Basic Concepts and Approaches -- Chapter 1: The “Correct” Definition of “the Impact of a Choice on Economic Efficiency” -- Chapter 2: The Components of the Difference Between a Firm’s Price and...

Introduction to This Study: This Study’s Coverage and Distinctive Features -- Chapter 12: Horizontal Mergers and Acquisitions -- Chapter 13: Conglomerate Mergers and Acquisitions -- Chapter 14: Vertical Mergers and the Pricing Techniques, Contract-of-Sale Provisions, and Sales-Policies That...

Infolge aktueller Entwicklungen in der Kartellrechtspraxis wird das Preisbindungsverbot derzeit wieder kontrovers unter Vertretern der Rechtswissenschaft, der Wettbewerbstheorie und der Betriebswirtschaftslehre diskutiert. Benjamin C. Schefer analysiert in diesem Zusammenhang die...

und Problemstellung -- Grundlagen und konzeptioneller Rahmen -- Bestimmungs- und Begrenzungsfaktoren der Gestaltung des Automobilvertriebs -- Analyse von Distributionsorganen -- Distributionsorgane des Automobilvertriebs im Spiegel einer Delphi-Studie -- Implikationen auf die...

In European Founders at Work, several of the top European startup founders and venture capitalists are interviewed to explain their respective paths to building a successful company. It takes a similar approach to Venture Capitalists at Work and other books in Apress' elite At Work series but...